Human induced pluripotent stem cells (hiPSCs) hold great hopes for application in regenerative medicine due to their inherent capacity to self-renew and differentiate into cells from the three embryonic germ layers. For clinical applications, a large quantity of hiPSCs produced in standardized and scalable culture processes is required. Several groups, including ours, have developed methodologies for scaled-up hiPSC production in stirred bioreactors in chemically defined medium. In this study, we optimized the critical steps and factors that affect hiPSC expansion and yield in stirred-suspension cultures, including inoculation conditions, seeding density, aggregate size, agitation rate, and cell passaging method. After multiple passages in stirred-suspension bioreactors, hiPSCs remained pluripotent, karyotypically normal, and capable of differentiating into all three germ layers.
Get full access to this article
View all access options for this article.
References
1.
NishikawaS, GoldsteinRA and NierrasCR. (2008). The promise of human induced pluripotent stem cells for research and therapy. Nat Rev Mol Cell Biol, 9:725–729.
2.
LeeH, ParkJ, ForgetBG and GainesP. (2009). Induced pluripotent stem cells in regenerative medicine: an argument for continued research on human embryonic stem cells. Regen Med, 4:759–769.
3.
RevillaA, GonzálezC, IriondoA, FernándezB, PrietoC, MarínC and ListeI. (2016). Current advances in the generation of human iPS cells: implications in cell-based regenerative medicine. J Tissue Eng Regen Med, 10:893–907.
4.
OhSK, ChenAK, MokY, ChenX, LimUM, ChinA, ChooAB and ReuvenyS. (2009). Long-term microcarrier suspension cultures of human embryonic stem cells. Stem Cell Res, 2:219–230.
5.
FanY, HsiungM, ChengC and TzanakakisES. (2014). Facile engineering of xeno-free microcarriers for the scalable cultivation of human pluripotent stem cells in stirred suspension. Tissue Eng Part A, 20:588–599.
6.
KehoeDE, JingD, LockLT and TzanakakisES. (2010). Scalable stirred-suspension bioreactor culture of human pluripotent stem cells. Tissue Eng Part A, 16:405–421.
7.
PhillipsBW, HorneR, LayTS, RustWL, TeckTT and CrookJM. (2008). Attachment and growth of human embryonic stem cells on microcarriers. J Biotechnol, 138:24–32.
8.
LockLT and TzanakakisES. (2009). Expansion and differentiation of human embryonic stem cells to endoderm progeny in a microcarrier stirred-suspension culture. Tissue Eng Part A, 15:2051–2063.
9.
BardyJ, ChenAK, LimYM, WuS, WeiS, WeipingH, ChanK, ReuvenyS and OhSK. (2013). Microcarrier suspension cultures for high-density expansion and differentiation of human pluripotent stem cells to neural progenitor cells. Tissue Eng Part C Methods, 19:166–180.
10.
LecinaM, TingS, ChooA, ReuvenyS and OhS. (2010). Scalable platform for human embryonic stem cell differentiation to cardiomyocytes in suspended microcarrier cultures. Tissue Eng Part C Methods, 16:1609–1619.
11.
BaradezMO and MarshallD. (2011). The use of multidimensional image-based analysis to accurately monitor cell growth in 3D bioreactor culture. PLoS One, 6:e26104.
12.
KrawetzR, TaianiJT, LiuS, MengG, LiX, KallosMS and RancourtDE. (2010). Large-scale expansion of pluripotent human embryonic stem cells in stirred-suspension bioreactors. Tissue Eng Part C Methods, 16:573–582.
13.
AmitM, ChebathJ, MarguletsV, LaevskyI, MiropolskyY, SharikiK, PeriM, BlaisI, SlutskyG, RevelM and Itskovitz-EldorJ. (2010). Suspension culture of undifferentiated human embryonic and induced pluripotent stem cells. Stem Cell Rev, 6:248–259.
14.
SinghH, MokP, BalakrishnanT, RahmatSN and ZweigerdtR. (2010). Up-scaling single cell-inoculated suspension culture of human embryonic stem cells. Stem Cell Res, 4:165–179.
15.
SteinerD, KhanerH, CohenM, Even-RamS, GilY, ItsyksonP, TuretskyT, IdelsonM, AizenmanE, et al. (2010). Derivation, propagation and controlled differentiation of human embryonic stem cells in suspension. Nat Biotechnol, 28:361–364.
16.
ZweigerdtR, OlmerR, SinghH, HaverichA and MartinU. (2011). Scalable expansion of human pluripotent stem cells in suspension culture. Nat Protoc, 6:689–700.
17.
AmitM, LaevskyI, MiropolskyY, SharikiK, PeriM and Itskovitz-EldorJ. (2011). Dynamic suspension culture for scalable expansion of undifferentiated human pluripotent stem cells. Nat Protoc, 6:572–579.
18.
AbbasalizadehS, LarijaniMR, SamadianA and BaharvandH. (2012). Bioprocess development for mass production of size-controlled human pluripotent stem cell aggregates in stirred suspension bioreactor. Tissue Eng Part C Methods, 18:831–851.
19.
OlmerR, LangeA, SelzerS, KasperC, HaverichA, MartinU and ZweigerdtR. (2012). Suspension culture of human pluripotent stem cells in controlled, stirred bioreactors. Tissue Eng Part C Methods, 18:772–784.
20.
ChenVC, CoutureSM, YeJ, LinZ, HuaG, HuangHI, WuJ, HsuD, CarpenterMK and CoutureLA. (2012). Scalable GMP compliant suspension culture system for human ES cells. Stem Cell Res, 8:388–402.
21.
HaraguchiY, MatsuuraK, ShimizuT, YamatoM and OkanoT. (2015). Simple suspension culture system of human iPS cells maintaining their pluripotency for cardiac cell sheet engineering. J Tissue Eng Regen Med, 9:1363–1375.
22.
WangY, ChouBK, DoweyS, HeC, GerechtS and ChengL. (2013). Scalable expansion of human induced pluripotent stem cells in the defined xeno-free E8 medium under adherent and suspension culture conditions. Stem Cell Res, 11:1103–1116.
23.
HuntMM, MengG, RancourtDE, GatesID and KallosMS. (2014). Factorial experimental design for the culture of human embryonic stem cells as aggregates in stirred suspension bioreactors reveals the potential for interaction effects between bioprocess parameters. Tissue Eng Part C Methods, 20:76–89.
24.
ElanzewA, SommerA, Pusch-KleinA, BrüstleO and HauptS. (2015). A reproducible and versatile system for the dynamic expansion of human pluripotent stem cells in suspension. Biotechnol J, 10:1589–1599.
25.
KallosMS and BehieLA. (1999). Inoculation and growth conditions for high-cell-density expansion of mammalian neural stem cells in suspension bioreactors. Biotechnol Bioeng, 63:473–483.
26.
WatanabeK, UenoM, KamiyaD, NishiyamaA, MatsumuraM, WatayaT, TakahashiJB, NishikawaS, NishikawaS, MugurumaK and SasaiY. (2007). A ROCK inhibitor permits survival of dissociated human embryonic stem cells. Nat Biotechnol, 25:681–686.
27.
PrescottC. (2011). The business of exploiting induced pluripotent stem cells. Philos Trans R Soc Lond B Biol Sci, 366:2323–2328.
28.
KnoepflerPS. (2012). Key anticipated regulatory issues for clinical use of human induced pluripotent stem cells. Regen Med, 7:713–720.
29.
CyranoskiD. (2012). Stem-cell pioneer banks on future therapies. Nature, 488:139.
30.
LipsitzYY, TimminsNE and ZandstraPW. (2016). Quality cell therapy manufacturing by design. Nat Biotechnol, 34:393–400.
31.
MandaiM, WatanabeA, KurimotoY, HiramiY, MorinagaC, DaimonT, FujiharaM, AkimaruH, SakaiN, et al. (2017). Autologous induced stem-cell-derived retinal cells for macular degeneration. N Engl J Med, 376:1038–1046.
32.
TaianiJT, KrawetzRJ, Zur NiedenNI, Elizabeth WuY, KallosMS, MatyasJR and RancourtDE. (2010). Reduced differentiation efficiency of murine embryonic stem cells in stirred suspension bioreactors. Stem Cells Dev, 9:989–998.
33.
GareauT, LaraGG, ShepherdRD, KrawetzR, RancourtDE, RinkerKD and KallosMS. (2014). Shear stress influences the pluripotency of murine embryonic stem cells in stirred suspension bioreactors. J Tissue Eng Regen Med, 8:268–278.
34.
MengG, LiuS and RancourtDE. (2011). Rapid isolation of undifferentiated human pluripotent stem cells from extremely differentiated colonies. Stem Cells Dev, 20:583–591.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
